Gynecologic cytology - Quo vadis?;Zervixzytologie - Quo vadis?

Geburtshilfe und Frauenheilkunde

Volumn 61, Issue 7, 2001, Pages 463-469

  Breitenecker, G ^a   Birner, P ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

CYTOLOGY; DRUG EFFICACY; GERMANY; GYNECOLOGY; HUMAN; PAPANICOLAOU TEST; QUALITY CONTROL; REVIEW; SAMPLING; SCREENING; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WART VIRUS;

EID: 0034896554     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15974     Document Type: Review

References (33)

1. Federal study shows conventional Pap test remains most effective way to diagnose cervical cancer
2. Guidelines for the cytopathology laboratory
3. Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology
4. Evaluation of the AutoCyte SCREEN system in a clinical cytopathology laboratory
5. Gynäkologische zytologie - Aktuelle probleme
6. Automatisation in der gynäkologischen zytologie
7. Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions
8. Spontaneous resolution of grade 1 cervical intraepithelial neoplasia in a private practice population
9. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely
10. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
11. Evaluation of screening program for gynecological cancer
12. Human papillomavirus types in routine cytological screening and at colposcopic examinations
13. Computerized screening devices and performance assessment: Developement of a policy towards automation
14. Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine
15. HPV-typisierung in der gynäkologischen praxis
16. Humanes papillomavirus - Vakzinierung gegen das zervixkarzinom
17. Qualitätskontrolle in der zervixzytologie: Vergleich von sieben abnahmeinstrumenten
18. The Papanicolaou test for cervical cancer: A triumph and a tragedy
19. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears
20. Interactive neural network-assisted screening. A clinical assessment
21. Incidence of Gardnerella vaginalis, Candida sp and human papillomavirus in cytological smears
22. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses
23. Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR
24. The Polarprobe-emerging technology for cervical cancer screening
25. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
26. Human papillomavirus infection. Frequency and association with cervical neoplasia in a young population
27. High-risk types of papillomavirus associated with the progression of cervical dysplasia to carcinoma
28. Cervical screening adjuncts: Recent advances
29. Prevalence, incidence, and estimated lifetime risk of cervical human papillomavirus infections in a nonselected Finnish female population
30. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial
31. Prevalence of self-reported cervical screening and impact on cervical cancer mortality in Austria